238 related articles for article (PubMed ID: 17624683)
21. Dietary n-6 and n-3 polyunsaturated fatty acids: from biochemistry to clinical implications in cardiovascular prevention.
Russo GL
Biochem Pharmacol; 2009 Mar; 77(6):937-46. PubMed ID: 19022225
[TBL] [Abstract][Full Text] [Related]
22. Fatty acid facts, Part III: Cardiovascular disease, or, a fish diet is not fishy.
Pauwels EK; Kostkiewicz M
Drug News Perspect; 2008 Dec; 21(10):552-61. PubMed ID: 19221636
[TBL] [Abstract][Full Text] [Related]
23. The polypill to prevent cardiovascular disease: physicians' perspectives.
Viera AJ
Curr Opin Cardiol; 2011 Sep; 26(5):438-42. PubMed ID: 21730826
[TBL] [Abstract][Full Text] [Related]
24. Implementation of a simple age-based strategy in the prevention of cardiovascular disease: the Polypill approach.
Wald DS; Wald NJ
J Eval Clin Pract; 2012 Jun; 18(3):612-5. PubMed ID: 21276141
[TBL] [Abstract][Full Text] [Related]
25. Prospects and possible pitfalls of a preventive Polypill: confessions of a health promotion convert.
Green LW
Eur J Clin Nutr; 2005 Aug; 59 Suppl 1():S4-8; discussion S9. PubMed ID: 16052194
[TBL] [Abstract][Full Text] [Related]
26. Prescription omega-3 fatty acids and their lipid effects: physiologic mechanisms of action and clinical implications.
Bays HE; Tighe AP; Sadovsky R; Davidson MH
Expert Rev Cardiovasc Ther; 2008 Mar; 6(3):391-409. PubMed ID: 18327998
[TBL] [Abstract][Full Text] [Related]
27. A "polypill" a day keeps heart disease away.
Health News; 2003 Sep; 9(9):5. PubMed ID: 14584468
[No Abstract] [Full Text] [Related]
28. A review of the possible role of the essential fatty acids and fish oils in the aetiology, prevention or pharmacotherapy of schizophrenia.
Akter K; Gallo DA; Martin SA; Myronyuk N; Roberts RT; Stercula K; Raffa RB
J Clin Pharm Ther; 2012 Apr; 37(2):132-9. PubMed ID: 21501206
[TBL] [Abstract][Full Text] [Related]
29. Is there evidence-based hypolipidemic treatment with clinical benefit beyond statins?
Goumas GS
Angiology; 2009; 60(1):93-8. PubMed ID: 19019838
[TBL] [Abstract][Full Text] [Related]
30. Lowering homocysteine levels may prevent cardiovascular impairments? Possible therapeutic behaviors.
Cacciapuoti F
Blood Coagul Fibrinolysis; 2012 Dec; 23(8):677-9. PubMed ID: 23135377
[TBL] [Abstract][Full Text] [Related]
31. The role of dietary n-6 fatty acids in the prevention of cardiovascular disease.
Willett WC
J Cardiovasc Med (Hagerstown); 2007 Sep; 8 Suppl 1():S42-5. PubMed ID: 17876199
[TBL] [Abstract][Full Text] [Related]
32. The cardiovascular polypill in high-risk patients.
Lafeber M; Spiering W; Singh K; Guggilla RK; Patil V; Webster R;
Eur J Prev Cardiol; 2012 Dec; 19(6):1234-42. PubMed ID: 22019908
[TBL] [Abstract][Full Text] [Related]
33. "Polypill-aspostatinoprilololazide folate"--coprescription for at the risk Asian Indian in chronic non communicable diseases.
Joshi SR
J Assoc Physicians India; 2005 Mar; 53():175-8. PubMed ID: 15926597
[No Abstract] [Full Text] [Related]
34. [The polypill as cardiovascular prophylactic: clinical trials].
Sandli OK; Spigset O; Slørdal L
Tidsskr Nor Laegeforen; 2014 Mar; 134(6):620-3. PubMed ID: 24670510
[TBL] [Abstract][Full Text] [Related]
35. Omega-3 fatty acids. Current status in cardiovascular medicine.
Schmidt EB; Dyerberg J
Drugs; 1994 Mar; 47(3):405-24. PubMed ID: 7514972
[TBL] [Abstract][Full Text] [Related]
36. Lipid management in the geriatric patient.
Nair AP; Darrow B
Endocrinol Metab Clin North Am; 2009 Mar; 38(1):185-206. PubMed ID: 19217519
[TBL] [Abstract][Full Text] [Related]
37. Fatty acid facts, Part I. Essential fatty acids as treatment for depression, or food for mood?
Pawels EK; Volterrani D
Drug News Perspect; 2008 Oct; 21(8):446-51. PubMed ID: 19034351
[TBL] [Abstract][Full Text] [Related]
38. Biological significance of essential fatty acids.
Das UN
J Assoc Physicians India; 2006 Apr; 54():309-19. PubMed ID: 16944615
[TBL] [Abstract][Full Text] [Related]
39. Fatty acids and cardiovascular disease.
Lecerf JM
Nutr Rev; 2009 May; 67(5):273-83. PubMed ID: 19386031
[TBL] [Abstract][Full Text] [Related]
40. Omega-3 polyunsaturated fatty acids and proxies of cardiovascular disease in hemodialysis: a prospective cohort study.
Vernaglione L; Cristofano C; Chimienti S
J Nephrol; 2008; 21(1):99-105. PubMed ID: 18264942
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
